Oct 24 (Reuters) - Laboratory operator Labcorp (LH.N), opens new tab beat Wall Street estimates for third-quarter profit and revenue on Thursday as strong demand for diagnostic tests offset a hit ...

NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S. As syphilis cases surge nationwide, the collaboration will ...

The test will be available to hospitals and clinicians by the end of 2024 and offered to patients directly through Labcorp Ondemand in 2025.

Labcorp finalized an agreement to acquire selected assets of Birmingham’s Lab Works on Nov. 12 to take over operations of Lab ...

Labcorp's robust market presence with a broad range of clinical lab tests and genomic testing. Financial resilience demonstrated by a solid balance sheet and consistent revenue streams.

Labcorp said its operating cash flow included a “use of cash” from Invitae, the San Francisco genetic testing company of which Labcorp acquired its assets out of bankruptcy in Q3. Labcorp's ...

We are excited about Invitae’s complementary cutting edge science, their genetic testing solutions and technology, which aligns strategically with Labcorp’s focus on specialty medicine and ...